We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer

By LabMedica International staff writers
Posted on 20 Mar 2023
Print article
Image: Biomarkers have shown promise for identifying early risk of pancreatic cancer (Photo courtesy of Pexels)
Image: Biomarkers have shown promise for identifying early risk of pancreatic cancer (Photo courtesy of Pexels)

The incidence of pancreatic cancer is increasing, although the cause of its growing prevalence remains unknown. Even if pancreatic cancer is detected in its early stages, it usually spreads cells throughout the body, leading to an elevated risk of recurrence. While the majority of precancerous cysts known as intraductal papillary mucinous neoplasms (IPMNs) do not progress to pancreatic cancer, existing diagnostic evaluations - comprising clinical, radiographic, laboratory, endoscopic, and cytologic analyses - exhibit an overall accuracy of about 60%. Earlier, less precise methods of characterizing IPMNs have failed to identify reliable cancer markers. Now, researchers have discovered a set of biomarkers that may help understand whether cysts on the pancreas are likely to remain benign or develop into cancer.

The discovery by a research team at Duke Health (Durham, NC, USA) is a crucial first step towards establishing a clinical method for classifying lesions on the pancreas that have the maximum risk of turning cancerous, allowing for their removal before they can start spreading. If the biomarker-based approach is successful, it could help overcome the biggest obstacle in reducing the risk of developing pancreatic cancer, which is rising and grows silently before being diagnosed usually during abdominal scans.

By using digital spatial profiling, it is possible to selectively analyze individual groups of cells. This approach was adopted by Duke researchers, allowing them to identify several genetic mutations that both promote and suppress the progression of pancreatic cancer. Additionally, they identified markers capable of distinguishing between two primary variants of IPMN, as well as found distinct markers for defining a third variant that usually results in less severe disease. Some studies have inferred that inflammation contributes significantly to pancreatic cancer development. A clinical trial being conducted at Duke aims to determine whether anti-inflammatory therapy can reduce cancer progression in IPMN patients.

“Most IPMNs will never progress to pancreas cancer, but by distinguishing which ones will progress, we are creating an opportunity to prevent an incurable disease from developing,” said senior author Peter Allen, M.D., chief of the Division of Surgical Oncology at in the Department of Surgery at Duke University School of Medicine. “We found very distinct markers for high-grade cell abnormalities, as well as for slow-growing subtypes. Our work now is focusing on finding it in the cyst fluid. If we can identify these unique markers in cyst fluid, it could provide the basis for a protein biopsy that would guide whether we should remove the cyst before cancer develops and spreads.”

Related Links:
Duke Health 

HLX
Gold Supplier
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
New
UHF RFID Tag and Inlay
AD-163u8
New
Immunoassay Analyzer
DxI 9000

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.